Tg Therapeutics (TGTX) Notes Payables (2010 - 2018)
Tg Therapeutics (TGTX) recorded quarterly Notes Payables of $67000.0 in Q4 2018, down 26.37% quarter-over-quarter from $91000.0 in Q3 2018, and down 47.66% on a YoY basis from $128000.0 in Q4 2017.
Tg Therapeutics (TGTX) Notes Payables (2010 - 2018) Analysis & Trends
Tg Therapeutics' Notes Payables history runs 9 years deep, the most recent figure standing at $67000.0 for Q4 2018.
- In Q4 2018, Notes Payables fell 47.66% year-over-year to $67000.0; the TTM figure through Dec 2018 stood at $67000.0 (down 47.66% YoY), while the FY2018 annual figure was $67000.0, down 47.66% from the prior year.
- Notes Payables was $67000.0 for Q4 2018 at Tg Therapeutics, down from $91000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $295360.0 in Q2 2015 to a low of $67000.0 in Q4 2018.
- Historically, Notes Payables has averaged $167637.4 across 5 years, with a median of $166935.5 in 2014.
- The sharpest annual moves came in 2014 and 2015: Notes Payables plunged 93.79% in 2014, then soared 135.57% in 2015.
- A 5-year view of Notes Payables shows it stood at $275190.0 in 2014, then dropped by 23.13% to $211549.0 in 2015, then tumbled by 67.44% to $68875.0 in 2016, then jumped by 85.84% to $128000.0 in 2017, then plunged by 47.66% to $67000.0 in 2018.
- The last three Notes Payables figures came in at $67000.0 (Q4 2018), $91000.0 (Q3 2018), and $210000.0 (Q2 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Tg Therapeutics | 7.71 Bn | 7.06 Bn | 171.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 67,000.00 |
| Sep 30, 2018 | 91,000.00 |
| Jun 30, 2018 | 210,000.00 |
| Mar 31, 2018 | 224,000.00 |
| Dec 31, 2017 | 128,000.00 |
| Sep 30, 2017 | 182,156.00 |
| Jun 30, 2017 | 152,568.00 |
| Mar 31, 2017 | 174,657.00 |
| Dec 31, 2016 | 68,875.00 |
| Sep 30, 2016 | 117,126.00 |
| Jun 30, 2016 | 90,564.00 |
| Mar 31, 2016 | 152,917.00 |
| Dec 31, 2015 | 211,549.00 |
| Sep 30, 2015 | 181,668.00 |
| Jun 30, 2015 | 295,360.00 |
| Mar 31, 2015 | 272,206.00 |
| Dec 31, 2014 | 275,190.00 |
| Sep 30, 2014 | 183,144.00 |
| Jun 30, 2014 | 159,214.00 |
| Mar 31, 2014 | 115,554.00 |